These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 33011049)

  • 1. Agents of Last Resort: An Update on Polymyxin Resistance.
    Yang Q; Pogue JM; Li Z; Nation RL; Kaye KS; Li J
    Infect Dis Clin North Am; 2020 Dec; 34(4):723-750. PubMed ID: 33011049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agents of Last Resort: Polymyxin Resistance.
    Kaye KS; Pogue JM; Tran TB; Nation RL; Li J
    Infect Dis Clin North Am; 2016 Jun; 30(2):391-414. PubMed ID: 27208765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Whole-Cell Screen Identifies Small Bioactives That Synergize with Polymyxin and Exhibit Antimicrobial Activities against Multidrug-Resistant Bacteria.
    Zimmerman SM; Lafontaine AJ; Herrera CM; Mclean AB; Trent MS
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of new polymyxin derivatives for multi-drug resistant Gram-negative infections.
    Brown P; Dawson MJ
    J Antibiot (Tokyo); 2017 Apr; 70(4):386-394. PubMed ID: 28074057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Teaching 'old' polymyxins new tricks: new-generation lipopeptides targeting gram-negative 'superbugs'.
    Velkov T; Roberts KD; Nation RL; Wang J; Thompson PE; Li J
    ACS Chem Biol; 2014 May; 9(5):1172-7. PubMed ID: 24601489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymyxin antibiotics for gram-negative infections.
    Arnold TM; Forrest GN; Messmer KJ
    Am J Health Syst Pharm; 2007 Apr; 64(8):819-26. PubMed ID: 17420197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial Susceptibility Testing for Polymyxins: Challenges, Issues, and Recommendations.
    Ezadi F; Ardebili A; Mirnejad R
    J Clin Microbiol; 2019 Apr; 57(4):. PubMed ID: 30541939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multidrug-Resistant Gram-Negative Pathogens: The Urgent Need for 'Old' Polymyxins.
    Paterson DL; Bonomo RA
    Adv Exp Med Biol; 2019; 1145():9-13. PubMed ID: 31364068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymyxins, the last-resort antibiotics: Mode of action, resistance emergence, and potential solutions.
    Mohapatra SS; Dwibedy SK; Padhy I
    J Biosci; 2021; 46(3):. PubMed ID: 34475315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactivation of Polymyxin by Hydrolytic Mechanism.
    Yin J; Wang G; Cheng D; Fu J; Qiu J; Yu Z
    Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30936102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymyxins: Antibacterial Activity, Susceptibility Testing, and Resistance Mechanisms Encoded by Plasmids or Chromosomes.
    Poirel L; Jayol A; Nordmann P
    Clin Microbiol Rev; 2017 Apr; 30(2):557-596. PubMed ID: 28275006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of the ATP Synthase Eliminates the Intrinsic Resistance of
    Vestergaard M; Nøhr-Meldgaard K; Bojer MS; Krogsgård Nielsen C; Meyer RL; Slavetinsky C; Peschel A; Ingmer H
    mBio; 2017 Sep; 8(5):. PubMed ID: 28874470
    [No Abstract]   [Full Text] [Related]  

  • 13. Mechanisms of bactericidal action and resistance of polymyxins for Gram-positive bacteria.
    Yin J; Meng Q; Cheng D; Fu J; Luo Q; Liu Y; Yu Z
    Appl Microbiol Biotechnol; 2020 May; 104(9):3771-3780. PubMed ID: 32157424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymyxins and their novel derivatives.
    Vaara M
    Curr Opin Microbiol; 2010 Oct; 13(5):574-81. PubMed ID: 20869908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MCR-1 Inhibition with Peptide-Conjugated Phosphorodiamidate Morpholino Oligomers Restores Sensitivity to Polymyxin in
    Daly SM; Sturge CR; Felder-Scott CF; Geller BL; Greenberg DE
    mBio; 2017 Nov; 8(6):. PubMed ID: 29114023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of Next Generation Polymyxins with Lower Toxicity: The Discovery of SPR206.
    Brown P; Abbott E; Abdulle O; Boakes S; Coleman S; Divall N; Duperchy E; Moss S; Rivers D; Simonovic M; Singh J; Stanway S; Wilson A; Dawson MJ
    ACS Infect Dis; 2019 Oct; 5(10):1645-1656. PubMed ID: 31525992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic antibacterial and anti-biofilm activities of resveratrol and polymyxin B against multidrug-resistant Pseudomonas aeruginosa.
    Qi L; Liang R; Duan J; Song S; Pan Y; Liu H; Zhu M; Li L
    J Antibiot (Tokyo); 2022 Oct; 75(10):567-575. PubMed ID: 35999263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymyxin B nonapeptide potentiates the eradication of Gram-negative bacterial persisters.
    Kim SJ; Jo J; Kim J; Ko KS; Lee W
    Microbiol Spectr; 2024 Apr; 12(4):e0368723. PubMed ID: 38391225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymyxin: Alternative Mechanisms of Action and Resistance.
    Trimble MJ; Mlynárčik P; Kolář M; Hancock RE
    Cold Spring Harb Perspect Med; 2016 Oct; 6(10):. PubMed ID: 27503996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymyxin Combinations Combat
    Bulman ZP; Chen L; Walsh TJ; Satlin MJ; Qian Y; Bulitta JB; Peloquin CA; Holden PN; Nation RL; Li J; Kreiswirth BN; Tsuji BT
    mBio; 2017 Jul; 8(4):. PubMed ID: 28743810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.